Metastatic melanoma after solid organ transplantation: An interdisciplinary, institution-based review of management with systemic and targeted therapies - 13/12/17

Shivani V. Tripathi, MD ^a, Caroline R. Morris, MD ^a, Tarek Alhamad, MD ^{b, c}, Ryan C. Fields, MD ^d, Gerald P. Linette, MD, PhD ^e, Lynn A. Cornelius, MD ^{a, ⁎}

^a Division of Dermatology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri 

^b Renal Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri 

^c Transplant Epidemiology Research Collaboration, Institute of Public Health, Washington University in St. Louis, St. Louis, Missouri 

^d Department of Surgery, Barnes Jewish Hospital and The Alvin J. Siteman Cancer Center, Washington University, St. Louis, Missouri 

^e Division of Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri 

^∗Reprint requests: Lynn A. Cornelius, MD, Division of Dermatology, Washington University School of Medicine, 660 S. Euclid Ave, Campus Box 8123, St. Louis, MO 63110Division of DermatologyWashington University School of Medicine660 S. Euclid Ave, Campus Box 8123St. LouisMO63110